Healthcare & Medical Devices Global On demand · 24-48h

Global Animal Breathing Anesthesia Machine Market Strategic Research Report

Global Animal Breathing Anesthesia Machine Market Strategic …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Animal Breathing Anesthesia Machine Market
$2202025
5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Basic Type, Ventilator-integrated Type, Workstation Type

By Application: Pet Hospitals and Clinics, Laboratory Animal and Research Institutes, Livestock and Large Animal Care, Exotic and Wildlife Animal Care

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: RWD Life Science, Mindray Animal Medical Technology, Vetland Medical, Midmark, Lory Progetti Veterinari, Rothacher Medical, SOMNI Scientifics, Kent Scientific, Dispomed, Acoma Medical, A.M. Bickford, VetEquip, Supera Anesthesia Innovations, JD Medical, Hallowell EMC, Vetamac, Eagle Eye Anesthesia, Shenzhen Comen Medical Instruments, Shenzhen Prunus Medical, Shanghai Raymain Information Technology, Shenzhen Bizvet Bio-tech, Dolphinmed, Shanghai TOW Intelligent Technology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 150 pages
Market size 2025
$220
Million USD
Forecast CAGR
5%
2025-2032
Forecast 2032
$309.6
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Animal Breathing Anesthesia Machine market size is predicted to grow from US$ 220 million in 2025 to US$ 309 million in 2032; it is expected to grow at a CAGR of 5.0% from 2026 to 2032.

Animal Breathing Anesthesia Machine is a type of veterinary medical equipment used for anesthesia delivery and respiratory support during animal surgery, clinical treatment, and laboratory procedures. It typically integrates oxygen supply, anesthetic gas delivery, vaporizers, breathing circuits, ventilators, monitoring modules, and waste gas management systems to support anesthesia induction, maintenance, ventilation control, and gas safety. The product is used for companion animals, laboratory animals, large animals, and exotic animals, and can be classified into basic veterinary anesthesia machines, anesthesia machines with ventilators, and veterinary anesthesia workstations depending on system configuration. In 2024, the global sales volume of veterinary respiratory anesthesia machines reached 20,000 units, with an average unit price of USD 8,900.

The upstream supply chain of Animal Breathing Anesthesia Machines mainly includes gas control components, sensors, valves, anesthetic vaporizers, breathing circuits, flowmeters, monitoring modules, medical gas interfaces, structural parts, and electronic control systems, as well as supporting materials such as metal parts, plastic components, seals, and software control modules. Midstream participants are veterinary anesthesia equipment manufacturers responsible for system design, integration, performance testing, and after-sales service. Downstream users include pet hospitals and clinics, laboratory animal and research institutes, livestock and large animal care facilities, zoos, and exotic animal care institutions, with companion animal care and laboratory animal research representing the major application areas.

From a market perspective, Animal Breathing Anesthesia Machines are benefiting from the professionalization of companion animal healthcare, increasing animal surgical procedures, stricter standards in laboratory animal research, and equipment upgrades in large animal care. Compared with traditional basic anesthesia devices, market demand is shifting toward safer, more stable, and more integrated anesthesia workstations and ventilator-equipped systems. International manufacturers still hold advantages in high-end anesthesia control, ventilation management, and system reliability, while Chinese manufacturers are accelerating substitution through cost advantages, faster product iteration, and local distribution channels. Future competition is expected to move beyond standalone equipment sales toward integrated anesthesia solutions, ease of clinical use, after-sales service capability, and application-specific product adaptation.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Animal Breathing Anesthesia Machine market?

What factors are driving Animal Breathing Anesthesia Machine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Animal Breathing Anesthesia Machine market opportunities vary by end market size?

How does Animal Breathing Anesthesia Machine break out by Type, by Application?

This report presents a comprehensive overview of the global Animal Breathing Anesthesia Machine market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Basic Type
  • Ventilator-integrated Type
  • Workstation Type

Segment by Animal Type

  • Small Animal Anesthesia Machine
  • Large Animal Anesthesia Machine
  • Laboratory Animal Anesthesia Machine

Segment by Equipment Structure

  • Tabletop Type
  • Cart-mounted Type
  • Wall-mounted Type

Segment by Application

  • Pet Hospitals and Clinics
  • Laboratory Animal and Research Institutes
  • Livestock and Large Animal Care
  • Exotic and Wildlife Animal Care

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Animal Breathing Anesthesia Machine market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pet Hospitals and Clinics, Laboratory Animal and Research Institutes, Livestock and Large Animal Care evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Animal Breathing Anesthesia Machine Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$220
2025
Forecast
$309.6
2032
CAGR
5%
2025–2032
Regions
5
global
Key companies
RWD Life ScienceMindray Animal Medical TechnologyVetland MedicalMidmarkLory Progetti VeterinariRothacher MedicalSOMNI ScientificsKent Scientific
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Basic TypeVentilator-integrated TypeWorkstation Type
By Application
Pet Hospitals and ClinicsLaboratory Animal and Research InstitutesLivestock and Large Animal CareExotic and Wildlife Animal Care

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Basic Type
  • 3.1.3 Ventilator-integrated Type
  • 3.1.4 Workstation Type
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pet Hospitals and Clinics
  • 4.1.3 Laboratory Animal and Research Institutes
  • 4.1.4 Livestock and Large Animal Care
  • 4.1.5 Exotic and Wildlife Animal Care
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 RWD Life Science
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Mindray Animal Medical Technology
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Vetland Medical
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Midmark
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Lory Progetti Veterinari
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Rothacher Medical
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 SOMNI Scientifics
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Kent Scientific
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Dispomed
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Acoma Medical
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 A.M. Bickford
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 VetEquip
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Supera Anesthesia Innovations
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 JD Medical
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Hallowell EMC
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Vetamac
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Eagle Eye Anesthesia
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Shenzhen Comen Medical Instruments
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Shenzhen Prunus Medical
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Shanghai Raymain Information Technology
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Shenzhen Bizvet Bio-tech
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Dolphinmed
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Shanghai TOW Intelligent Technology
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Animal Breathing Anesthesia Machine market?
The global Animal Breathing Anesthesia Machine market is estimated at US$ 220 million in 2025 (base year) and is projected to reach US$ 309 million by 2032.
What is the forecast CAGR for the Animal Breathing Anesthesia Machine market?
The market is expected to grow at a CAGR of 5.0% from 2026 to 2032, expanding from US$ 220 million in 2025 to US$ 309 million in 2032, roughly 1.4 times its base-year value.
What is Animal Breathing Anesthesia Machine?
Animal Breathing Anesthesia Machine is a type of veterinary medical equipment used for anesthesia delivery and respiratory support during animal surgery, clinical treatment, and laboratory procedures. It typically integrates oxygen supply, anesthetic gas delivery, vaporizers, breathing circuits, ventilators, monitoring modules, and waste gas management systems to support anesthesia induction, maintenance, ventilation control, and gas safety.
What are the main segments of the Animal Breathing Anesthesia Machine market by type?
By type, the market is segmented into Basic Type, Ventilator-integrated Type and Workstation Type.
Which applications drive demand in the Animal Breathing Anesthesia Machine market?
Key applications covered include Pet Hospitals and Clinics, Laboratory Animal and Research Institutes, Livestock and Large Animal Care and Exotic and Wildlife Animal Care.
Who are the key players in the Animal Breathing Anesthesia Machine market?
Key players profiled include RWD Life Science, Mindray Animal Medical Technology, Vetland Medical, Midmark, Lory Progetti Veterinari, Rothacher Medical, SOMNI Scientifics and Kent Scientific, among 23 companies covered in total.
Which regions and countries are covered for Animal Breathing Anesthesia Machine?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Animal Breathing Anesthesia Machine market?
What factors are driving Animal Breathing Anesthesia Machine market growth, globally and by region?
Who should buy the Animal Breathing Anesthesia Machine market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pet Hospitals and Clinics, Laboratory Animal and Research Institutes and Livestock and Large Animal Care, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Animal Breathing Anesthesia Machine market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.